Many thanks for your ongoing support to the study. As of mid-October 2024, we have recruited 2437 participants of our 3000 target.
We are hoping to complete participant recruitment by the end of the year, so there is still time to take part.
If you have been diagnosed with any of the following conditions, are a registered patient at any of our 11 recruiting sites (Birmingham, Cardiff, Glasgow, Imperial, Leicester, Newcastle, Nottingham, Oxford, Portsmouth, Sheffield, Southampton) and would like to take part, please contact us on our study email stravinsky@contacts.bham.ac.uk stating which condition you have been diagnosed with, and which hospital your consultant is based at.
Conditions:
- Multiple myeloma
- Myelodysplastic syndrome
- Polycythaemia vera
- Essential thrombocythaemia or thrombocytosis
- Sickle cell disease, thalassaemia or other inherited anaemia
- Down’s syndrome or any learning disability
- A neurological disease e.g. Parkinson’s, motor neurone disease, multiple sclerosis*
- HIV
- Common variable immunodeficiency and secondary immunodeficiency (An immunodeficiency and is receiving prophylactic antibiotics and/or immunoglobulin)
- Liver cirrhosis
- Chronic respiratory conditions (e.g. asthma, COPD, bronchiectasis, cystic fibrosis and pulmonary fibrosis and under a respiratory specialist*
- Diabetes mellitus*
- Heart failure and under the care of cardiology
- Received a stem cell transplant in the last year
- Received or receiving radiotherapy in the last 6 months
*Open to those who would like to take part face-to-face only i.e. registered patient at Southampton, Oxford, Imperial or Birmingham